Ovarex MAB is a monoclonal antibody (biologic) is on clinical trial trying to delay recurrence. On phase II it has a success rate
of 50%. I would say clinical trial is a must if we have to find a cure for OvCA. I wouldn't be surprise if a clinical trial on a combination of Avastin/tarceva
/Phenoxodiol/low dose chemo or chemo combo (can be any combo among Taxol/Carboplatin/Taxotere/Doxil/Gemzar,Topotecan, etc.) would be in the market pretty soon and be a final cure for Ovarian CA.